Rhythm Pharmaceuticals, Inc.
RYTM
$50.97
$0.731.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -41.11% | -39.56% | -42.36% | -51.70% | -1.97% |
| Total Depreciation and Amortization | -11.09% | -10.43% | -7.23% | -4.10% | 5.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 220.78% | 175.49% | 243.75% | 319.61% | 79.08% |
| Change in Net Operating Assets | 119.99% | 587.18% | 120.24% | 98.48% | 127.61% |
| Cash from Operations | 16.36% | 11.62% | 18.96% | 10.09% | 21.49% |
| Capital Expenditure | -- | 102.13% | 100.00% | 100.00% | 83.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -757.48% | 32.36% | -271.69% | 122.92% | -119.84% |
| Cash from Investing | -750.36% | 32.41% | -267.89% | 122.75% | -120.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -1.75% | -73.42% | -54.95% | -55.59% | -59.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -123.57% | -116.38% | -29.23% | -78.11% | -76.54% |
| Cash from Financing | 157.16% | 73.93% | 29.20% | -63.08% | -65.22% |
| Foreign Exchange rate Adjustments | 101.41% | -2,434.00% | -1,703.70% | -447.67% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 143.19% | 85.94% | 1,761.77% | -280.25% | -198.78% |
